Literature DB >> 2016758

Human T-cell leukemia virus (HTLV) type II Rex protein binds specifically to RNA sequences of the HTLV long terminal repeat but poorly to the human immunodeficiency virus type 1 Rev-responsive element.

M T Yip1, W S Dynan, P L Green, A C Black, S J Arrigo, A Torbati, S Heaphy, C Ruland, J D Rosenblatt, I S Chen.   

Abstract

The human T-cell leukemia viruses (HTLVs) encode a trans-regulatory protein, Rex, which differentially regulates viral gene expression by controlling the cytoplasmic accumulation of viral mRNAs. Because of insufficient amounts of purified protein, biochemical characterization of Rex activity has not previously been performed. Here, utilizing the baculovirus expression system, we purified HTLV type II (HTLV-II) Rex from the cytoplasmic fraction of recombinant baculovirus-infected insect cells by heparin-agarose chromatography. We directly demonstrated that Rex specifically bound HTLV-II 5' long terminal repeat RNA in both gel mobility shift and immunobinding assays. Sequences sufficient for Rex binding were localized to the R-U5 region of the HTLV-II 5' long terminal repeat and correlate with the region required for Rex function. The human immunodeficiency virus type 1 (HIV-1), has an analogous regulatory protein, Rev, which directly binds to and mediates its action through the Rev-responsive element located within the HIV-1 env gene. We demonstrated that HTLV-II Rex rescued an HIV-1JR-CSF Rev-deficient mutant, although inefficiently. This result is consistent with a weak binding activity to the HIV-1 Rev-responsive element under conditions in which it efficiently bound the HTLV-II long terminal repeat RNA.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2016758      PMCID: PMC240575     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  Structure of 3' terminal region of type II human T lymphotropic virus: evidence for new coding region.

Authors:  W A Haseltine; J Sodroski; R Patarca; D Briggs; D Perkins; F Wong-Staal
Journal:  Science       Date:  1984-07-27       Impact factor: 47.728

2.  Cloning in single-stranded bacteriophage as an aid to rapid DNA sequencing.

Authors:  F Sanger; A R Coulson; B G Barrell; A J Smith; B A Roe
Journal:  J Mol Biol       Date:  1980-10-25       Impact factor: 5.469

3.  Long terminal repeats of human T-cell leukaemia virus II genome determine target cell specificity.

Authors:  I S Chen; J McLaughlin; D W Golde
Journal:  Nature       Date:  1984 May 17-23       Impact factor: 49.962

4.  Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease.

Authors:  M Yoshida; I Miyoshi; Y Hinuma
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

5.  Low prevalence in the UK of HTLV-I and HTLV-II infection in subjects with AIDS, with extended lymphadenopathy, and at risk of AIDS.

Authors:  R S Tedder; D C Shanson; D J Jeffries; R Cheingsong-Popov; P Clapham; A Dalgleish; K Nagy; R A Weiss
Journal:  Lancet       Date:  1984-07-21       Impact factor: 79.321

6.  HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure.

Authors:  J A Zack; S J Arrigo; S R Weitsman; A S Go; A Haislip; I S Chen
Journal:  Cell       Date:  1990-04-20       Impact factor: 41.582

7.  A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia.

Authors:  V S Kalyanaraman; M G Sarngadharan; M Robert-Guroff; I Miyoshi; D Golde; R C Gallo
Journal:  Science       Date:  1982-11-05       Impact factor: 47.728

8.  Expression of the 3' terminal region of human T-cell leukemia viruses.

Authors:  W Wachsman; K Shimotohno; S C Clark; D W Golde; I S Chen
Journal:  Science       Date:  1984-10-12       Impact factor: 47.728

9.  Nucleotide sequence of the 3' region of an infectious human T-cell leukemia virus type II genome.

Authors:  K Shimotohno; W Wachsman; Y Takahashi; D W Golde; M Miwa; T Sugimura; I S Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

10.  Trans-acting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells.

Authors:  J G Sodroski; C A Rosen; W A Haseltine
Journal:  Science       Date:  1984-07-27       Impact factor: 47.728

View more
  15 in total

Review 1.  The human T-cell leukemia virus Rex protein.

Authors:  Ihab Younis; Patrick L Green
Journal:  Front Biosci       Date:  2005-01-01

2.  Dominant-negative mutants are clustered in a domain of the human T-cell leukemia virus type I Rex protein: implications for trans dominance.

Authors:  I Weichselbraun; J Berger; M Dobrovnik; H Bogerd; R Grassmann; W C Greene; J Hauber; E Böhnlein
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

3.  Human T-cell leukemia virus type 2 Rex inhibits pre-mRNA splicing in vitro at an early stage of spliceosome formation.

Authors:  A Bakker; X Li; C T Ruland; D W Stephens; A C Black; J D Rosenblatt
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

4.  Phosphorylation of two serine residues regulates human T-cell leukemia virus type 2 Rex function.

Authors:  M Narayan; K Kusuhara; P L Green
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

5.  Polypyrimidine tract-binding protein and heterogeneous nuclear ribonucleoprotein A1 bind to human T-cell leukemia virus type 2 RNA regulatory elements.

Authors:  A C Black; J Luo; C Watanabe; S Chun; A Bakker; J K Fraser; J P Morgan; J D Rosenblatt
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

6.  Human T-cell leukemia virus type 2 Rex carboxy terminus is an inhibitory/stability domain that regulates Rex functional activity and viral replication.

Authors:  Li Xie; Matthew Kesic; Brenda Yamamoto; Min Li; Ihab Younis; Michael D Lairmore; Patrick L Green
Journal:  J Virol       Date:  2009-03-11       Impact factor: 5.103

7.  Dominant negative mutants of human T-cell leukemia virus type I Rex and human immunodeficiency virus type 1 Rev fail to multimerize in vivo.

Authors:  H Bogerd; W C Greene
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

Review 8.  The use of baculoviruses as expression vectors.

Authors:  I M Kidd; V C Emery
Journal:  Appl Biochem Biotechnol       Date:  1993 Aug-Sep       Impact factor: 2.926

9.  Human T-cell leukemia virus type II Rex binding and activity require an intact splice donor site and a specific RNA secondary structure.

Authors:  A C Black; C T Ruland; M T Yip; J Luo; B Tran; A Kalsi; E Quan; M Aboud; I S Chen; J D Rosenblatt
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

10.  Functional domain structure of human T-cell leukemia virus type 2 rex.

Authors:  Murli Narayan; Ihab Younis; Donna M D'Agostino; Patrick L Green
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.